⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

Official Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF PALBOCICLIB (ORAL CDK 4/6 INHIBITOR) PLUS LETROZOLE VERSUS PLACEBO PLUS LETROZOLE FOR THE TREATMENT OF PREVIOUSLY UNTREATED ASIAN POSTMENOPAUSAL WOMEN WITH ER (+), HER2 (-) ADVANCED BREAST CANCER

Study ID: NCT02297438

Study Description

Brief Summary: The study is designed to compare the clinical benefit following treatment with letrozole in combination with Palbociclib versus letrozole in combination with placebo in Asian postmenopausal women with ER(+)/HER2(-) advanced breast cancer who have not received prior systemic anti cancer therapies for their advanced/metastatic disease.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

The First Affiliated Hospital of Bengbu Medical College/Medical Oncology Department, Bengbu, Anhui, China

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

Fujian Medical University Union Hospital/Medical Oncology Department, Fuzhou, Fujian, China

Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China

Zhongshan Ophthalmic Center,Sun Yat-Sen University, Guangzhou, Guangdong, China

Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

Breast Tumor Center, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Harbin Medical University Cancer Hospital/Oncology Department, Harbin, Heilongjiang, China

Henan Cancer Hospital, Zhengzhou, Henan, China

Hubei Cancer Hospital, Wuhan, Hubei, China

The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Hunan Provincial Tumor Hospital/Breast Internal Medicine Department, Changsha, Hunan, China

Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

Jiangsu Province Hospital, Nanjing, Jiangsu, China

The First Hospital of Jilin University, Changchun, Jilin, China

Jilin Provincial Cancer Hospital, Changchun, Jilin, China

The First Hospital of China Medical University/Oncology Department, Shenyang, Liaoning, China

Liaoning Province Cancer Hospital, Shenyang, Liaoning, China

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

West China Hospital of Sichuan University, Chengdu, Sichuan, China

Tianjin Cancer Hospital/Breast cancer department, Tianjin, Tianjin, China

The Tumor Hospital of Yunnan Province, Kunming, Yunnan, China

The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, , China

307 Hospital of PLA, Beijing, , China

Beijing Cancer Hospital, Beijing, , China

Peking University Third Hospital/Department of Oncology, Beijing, , China

Chinese PLA General Hospital/Oncology, Beijing, , China

Oncology Department, the Second Affiliated Hospital of Third Military Medical University, PLA, Chongqing City, , China

Fudan University Shanghai Cancer Center, Shanghai, , China

Block R, Hong Kong, , Hong Kong

Department of Clinical Oncology, Hong Kong, , Hong Kong

Queen Mary Hospital, Hong Kong, , Hong Kong

Queen Mary Hospital, HongKong, , Hong Kong

Raffles Cancer Centre, Singapore, , Singapore

Parkway Cancer Centre, Singapore, , Singapore

Tan Tock Seng Hospital, Singapore, , Singapore

Tan Tock Seng Hospital, Singapore, , Singapore

China Medical University Hospital, Taichung, , Taiwan

National Cheng Kung University Hospital / Internal Medicine, Tainan, , Taiwan

National Taiwan University Hospital, Taipei, , Taiwan

Mackay Memorial Hospital, Taipei, , Taiwan

Taipei Medical University Hospital/ Department of Surgery, Taipei, , Taiwan

Taipei Veterans General Hospital/Surgery Department, Taipei, , Taiwan

Koo Foundation, Sun Yat-Sen Cancer Center, Taipei, , Taiwan

Taipei Municipal Wanfang Hospital (Managed by Taipei Medical University ), Taipei, , Taiwan

King Chulalongkorn Memorial Hospital, Pathumwan, Bangkok, Thailand

Chula Clinical Research Center (Chula CRC), Patumwan, Bangkok, Thailand

Division of Therapeutic Radiology and Oncology, Department of Radiology, Muang, Chiang MAI, Thailand

Department of Medicine, Faculty of Medicine, Naresuan University, Muang, Phitsanulok, Thailand

Ramathibodi Hospital, Mahidol University, Bangkok, Ratchathevi, Thailand

Oncology Unit, Department of Internal Medicine, Phramongkutklao Hospital, Bangkok, , Thailand

Division of Medical Oncology, Department of Medicine,, Bangkok, , Thailand

Contact Details

Name: Pfizer CT.gov Call Center

Affiliation: Pfizer

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: